Showing results (41-50 of 149) with videos related to
Sort By:
Pageof 15
Annals of Hematology|February 23, 2018
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatmentMassimo Breccia, Francesca Palandri, Luigiana Luciano, et al.Journal of Clinical Medicine|November 27, 2024
Arterial Stiffness as a New Predictor of Clinical Outcome in Patients with Polycythemia VeraOlga Mulas, Alessandro Sestu, Alessandro Costa, et al.Pharmaceutics|March 28, 2024
A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid LeukemiaSara Galimberti, Elisabetta Abruzzese, Giacomo Luci, et al.Experimental Hematology|March 9, 2010
Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patientsGiovanni Caocci, Roberto Baccoli, Adriana Vacca, et al.Annals of Hematology|April 26, 2024
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpuraOlga Mulas, Fabio Efficace, Alessandro Costa, et al.Annals of Hematology|January 17, 2025
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant managementAlessandro Costa, Federica Pilo, Martina Pettinau, et al.Vaccines|July 27, 2022
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 VaccineAndrea Galitzia, Luca Barabino, Roberta Murru, et al.Cellular Signalling|January 10, 2015
T cell tyrosine phosphorylation response to transient redox stressChristian Secchi, Marissa Carta, Claudia Crescio, et al.Blood|August 21, 2013
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemiaGiorgio La Nasa, Giovanni Caocci, Fabio Efficace, et al.Journal of Clinical Medicine|January 11, 2024
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid LeukemiaAlessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, et al.Pageof 15